Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12006369 BCMA chimeric antigen receptors

Patent 12006369 was granted and assigned to 2seventy bio, Inc. on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

2seventy bio, Inc.

Current Assignee

2seventy bio, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120063690

Patent Inventor Names

Richard Morgan0

Kevin Friedman0

Date of Patent

June 11, 2024

Patent Application Number

165158700

Date Filed

July 18, 2019

Patent Citations

‌

US Patent 7067318 Methods for transfecting T cells

‌

US Patent 7144575 Methods for selectively stimulating proliferation of T cells

‌

US Patent 7172869 Methods for transfecting T cells

‌

US Patent 7175843 Methods for selectively stimulating proliferation of T cells

‌

US Patent 7232566 Methods for treating HIV infected subjects

‌

US Patent 7754482 Artificial antigen presenting cells and uses therefor

‌

US Patent 7977095 Generation and isolation of antigen-specific T cells

‌

US Patent 9034324 Anti-BCMA antibodies

...

Patent Citations Received

‌

US Patent 12109234 Anti-BCMA CAR T cell compositions

Patent Primary Examiner

‌

Brad Duffy

Patent abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12006369 BCMA chimeric antigen receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API